- Home
- EBMT vs ELUT Comparison
EBMT vs ELUT Comparison
Compare EBMT & ELUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | EBMT | ELUT |
|---|---|---|
| Founded | 1922 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 163.1M | 48.3M |
| IPO Year | 2009 | 2020 |
Fundamental Metrics
Financial Performance| Metric | EBMT | ELUT |
|---|---|---|
| Price | $21.80 | $1.10 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $23.00 | $6.00 |
| AVG Volume (30 Days) | 64.8K | ★ 67.0K |
| Earning Date | 05-05-2026 | 05-08-2026 |
| Dividend Yield | ★ 2.66% | N/A |
| EPS Growth | 53.23 | ★ 146.77 |
| EPS | ★ 1.90 | 0.87 |
| Revenue | N/A | ★ $12,293,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $5.00 | $10.83 |
| P/E Ratio | $11.45 | ★ $1.33 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $15.11 | $0.50 |
| 52 Week High | $23.75 | $2.60 |
Technical Indicators
Market Signals| Indicator | EBMT | ELUT |
|---|---|---|
| Relative Strength Index (RSI) | 55.99 | 47.49 |
| Support Level | $16.02 | $1.00 |
| Resistance Level | $22.39 | $1.16 |
| Average True Range (ATR) | 0.51 | 0.06 |
| MACD | 0.04 | -0.00 |
| Stochastic Oscillator | 54.59 | 22.19 |
Price Performance
Historical ComparisonAbout EBMT Eagle Bancorp Montana Inc.
Eagle Bancorp Montana Inc operates as a bank holding company. It provides loan and deposit services. The company focuses on residential loans, commercial real estate loans, commercial loans, consumer loans, and home equity loan products. The bank also offers deposit accounts which include checking, savings, money market, individual retirement accounts, and certificates of deposit accounts. It is a diversified lender with a focus on residential mortgage loans, commercial real estate mortgage loans, commercial business loans, agricultural loans, and second mortgage/home equity loan products.
About ELUT Elutia Inc.
Elutia Inc develops proprietary drug-eluting biomatrix products for use in surgical reconstruction and related applications. These products are designed to improve the interaction between implanted medical devices and patients. Its products include CanGaroo, designed for implantable electronic devices, and SimpliDerm, used in soft tissue repair, with functions related to implant support and wound management. The company operates in two segments: Women's Health and Cardiovascular. The majority of revenue is derived from the Women's Health segment.